To hear about similar clinical trials, please enter your email below
Trial Title:
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
NCT ID:
NCT05907681
Condition:
Breast Cancer
Metastatic Breast Cancer
Radiation Therapy Complication
Conditions: Official terms:
Breast Neoplasms
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
This study is a prospective observational study on outcomes of high precision
hypo-fractionated radiotherapy in breast cancer with distant metastasis.
Criteria for eligibility:
Study pop:
Women treated with hypofractionated RT using IMRT, SBRT, or proton therapy for metastatic
breast cancer
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- histologically confirmed breast cancer
- presence of distant metastasis
- radiation therapy using IMRT, SBRT, or proton therapy is done or planned
- Able and willing to comply with the study protocol
Exclusion Criteria:
- unable to adhere to the study protocol
Gender:
Female
Minimum age:
19 Years
Maximum age:
100 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Samsung Medical Center
Address:
City:
Seoul
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Last name:
Won Park
Email:
wonro.park@samsung.com
Start date:
May 11, 2023
Completion date:
December 31, 2033
Lead sponsor:
Agency:
Samsung Medical Center
Agency class:
Other
Source:
Samsung Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05907681
